Last updated on June 2020

Long Term Safety and Efficacy of Pasireotide s.c. in Patients With Cushing's Disease

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Cushing's disease
  • Age: Between 18 - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Male or female patients aged 18 years or older with a diagnosis of Cushing's disease for whom surgery has failed or for whom surgery is not an option
  • Patients must be treated with pasireotide s.c. started either at the first visit for this study or prior to study entry

Exclusion Criteria:

  • Patients with ectopic ACTH-dependent Cushing's syndrome
  • Patients with adrenal Cushing's syndrome
  • Patients with Pseudo Cushing's syndrome

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.